These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20660733)

  • 21. Understanding the structure-function relationship between FGF19 and its mitogenic and metabolic activities.
    Wu X; Li Y
    Adv Exp Med Biol; 2012; 728():195-213. PubMed ID: 22396171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF19 and FGF21 for the Treatment of NASH-Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human.
    Henriksson E; Andersen B
    Front Endocrinol (Lausanne); 2020; 11():601349. PubMed ID: 33414764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of the Proliferative Potential of FGF21 or FGF19 in Liver-Specific FGFR4-Deficient Mice.
    Wäse K; Bartels T; Schwahn U; Kabiri M
    Toxicol Pathol; 2023 Jan; 51(1-2):27-38. PubMed ID: 37098695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating FGF19 and FGF21 surge in early infancy from infra- to supra-adult concentrations.
    Sánchez-Infantes D; Gallego-Escuredo JM; Díaz M; Aragonés G; Sebastiani G; López-Bermejo A; de Zegher F; Domingo P; Villarroya F; Ibáñez L
    Int J Obes (Lond); 2015 May; 39(5):742-6. PubMed ID: 25599612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Klotho and fibroblast growth factors 19 and 21 serum concentrations in children and adolescents with normal body weight and obesity and their associations with metabolic parameters.
    Socha-Banasiak A; Michalak A; Pacześ K; Gaj Z; Fendler W; Socha A; Głowacka E; Kapka K; Gołąbek V; Czkwianianc E
    BMC Pediatr; 2020 Jun; 20(1):294. PubMed ID: 32546231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis.
    Wu X; Li Y
    Aging (Albany NY); 2009 Dec; 1(12):1023-7. PubMed ID: 20157585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
    Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
    Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
    J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.
    Degirolamo C; Sabbà C; Moschetta A
    Nat Rev Drug Discov; 2016 Jan; 15(1):51-69. PubMed ID: 26567701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.
    Izaguirre M; Gil MJ; Monreal I; Montecucco F; Frühbeck G; Catalán V
    Curr Diab Rep; 2017 Jun; 17(6):43. PubMed ID: 28451950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways.
    Wu AL; Coulter S; Liddle C; Wong A; Eastham-Anderson J; French DM; Peterson AS; Sonoda J
    PLoS One; 2011 Mar; 6(3):e17868. PubMed ID: 21437243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
    Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
    FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives.
    Somm E; Jornayvaz FR
    Endocr Rev; 2018 Dec; 39(6):960-989. PubMed ID: 30124818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factors: new insights, new targets in the management of diabetes.
    Kyrou I; Weickert MO; Gharanei S; Randeva HS; Tan BK
    Minerva Endocrinol; 2017 Sep; 42(3):248-270. PubMed ID: 27412358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced levels of serum FGF19 and impaired expression of receptors for endocrine FGFs in adipose tissue from HIV-infected patients.
    Gallego-Escuredo JM; Domingo P; Gutiérrez Mdel M; Mateo MG; Cabeza MC; Fontanet A; Vidal F; Domingo JC; Giralt M; Villarroya F
    J Acquir Immune Defic Syndr; 2012 Dec; 61(5):527-34. PubMed ID: 23187887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
    Iglesias P; Selgas R; Romero S; Díez JJ
    Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor 19 regulates skeletal muscle mass and ameliorates muscle wasting in mice.
    Benoit B; Meugnier E; Castelli M; Chanon S; Vieille-Marchiset A; Durand C; Bendridi N; Pesenti S; Monternier PA; Durieux AC; Freyssenet D; Rieusset J; Lefai E; Vidal H; Ruzzin J
    Nat Med; 2017 Aug; 23(8):990-996. PubMed ID: 28650457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine FGFs and their signaling in the brain: Relevance for energy homeostasis.
    Zangerolamo L; Carvalho M; Velloso LA; Barbosa HCL
    Eur J Pharmacol; 2024 Jan; 963():176248. PubMed ID: 38056616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast Growth Factor-Based Pharmacotherapies for the Treatment of Obesity-Related Metabolic Complications.
    Jin L; Yang R; Geng L; Xu A
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():359-382. PubMed ID: 36100222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.